158 related articles for article (PubMed ID: 16751382)
1. CD4+ T cells can protect APC from CTL-mediated elimination.
Mueller SN; Jones CM; Stock AT; Suter M; Heath WR; Carbone FR
J Immunol; 2006 Jun; 176(12):7379-84. PubMed ID: 16751382
[TBL] [Abstract][Full Text] [Related]
2. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
Smith CM; Belz GT; Wilson NS; Villadangos JA; Shortman K; Carbone FR; Heath WR
J Immunol; 2003 May; 170(9):4437-40. PubMed ID: 12707318
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
5. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
6. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
7. Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
Meyer zum Büschenfelde C; Nicklisch N; Rose-John S; Peschel C; Bernhard H
J Immunol; 2000 Oct; 165(7):4133-40. PubMed ID: 11034426
[TBL] [Abstract][Full Text] [Related]
8. The cross-priming APC requires a Rel-dependent signal to induce CTL.
Mintern JD; Belz G; Gerondakis S; Carbone FR; Heath WR
J Immunol; 2002 Apr; 168(7):3283-7. PubMed ID: 11907083
[TBL] [Abstract][Full Text] [Related]
9. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
[TBL] [Abstract][Full Text] [Related]
10. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
11. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
12. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus.
Mueller SN; Jones CM; Smith CM; Heath WR; Carbone FR
J Exp Med; 2002 Mar; 195(5):651-6. PubMed ID: 11877488
[TBL] [Abstract][Full Text] [Related]
13. Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL.
Luketic L; Delanghe J; Sobol PT; Yang P; Frotten E; Mossman KL; Gauldie J; Bramson J; Wan Y
J Immunol; 2007 Oct; 179(8):5024-32. PubMed ID: 17911587
[TBL] [Abstract][Full Text] [Related]
14. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells.
Herter S; Osterloh P; Hilf N; Rechtsteiner G; Höhfeld J; Rammensee HG; Schild H
J Immunol; 2005 Jul; 175(2):891-8. PubMed ID: 16002687
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL.
Nelson DJ; Mukherjee S; Bundell C; Fisher S; van Hagen D; Robinson B
J Immunol; 2001 May; 166(9):5557-66. PubMed ID: 11313395
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
[TBL] [Abstract][Full Text] [Related]
18. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.
Salio M; Shepherd D; Dunbar PR; Palmowski M; Murphy K; Wu L; Cerundolo V
J Immunol; 2001 Aug; 167(3):1188-97. PubMed ID: 11466333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
